<DOC>
	<DOCNO>NCT01439854</DOCNO>
	<brief_summary>The purpose study examine effect chronic treatment type 2 diabetes ( T2DM ) dapagliflozin : ( 1 ) mitochondrial gene function/expression insulin signaling/action ( 2 ) oral glucose tolerance beta cell function . Dapagliflozin potent , highly specific inhibitor renal glucose transport [ SGLT2 ] .</brief_summary>
	<brief_title>Study Dapagliflozin Mitochondrial Dysfunction Impaired Insulin Signaling/Action</brief_title>
	<detailed_description>`` Glucotoxicity '' implicate cause insulin resistance impair beta cell function T2DM . Abundant support glucotoxicity hypothesis provide vivo vitro study animal , rigorous test hypothesis man lack . The investigator propose test glucotoxicity hypothesis chronically reduce plasma glucose type 2 diabetic subject ( T2DM ) inhibitor renal glucose transport , dapaglifozin , examine effect restoration normoglycemia mitochondrial function insulin signaling/sensitivity . Lastly , investigator test `` glucolipotoxicity '' hypothesis , state toxic effect elevate plasma FFA insulin sensitive tissue ( i.e. , muscle ) magnify presence concurrent hyperglycemia . Thus , high glucose level increase malonyl CoA , inhibit CPT I , lead accumulation FACoA/DAG , impair mitochondrial function inhibit insulin action .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>T2DM Drug Naive Or On Oral Therapy Insulin Treatment Major Organ Disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Mitochondrial function</keyword>
	<keyword>Glucose toxicity</keyword>
	<keyword>Glucosuria</keyword>
</DOC>